PLX157220

GSE113685: Metabolic adaptations underlie epigenetic vulnerabilities in chemoresistant breast cancer. [RNA-Seq2]

• Organsim human
• Type RNASEQ
• Target gene
• Project ARCHS4

Purpose:Assess the difference in gene expression of taxol-resistant TNBC cells relative to parental cells (MDA-MB-436 and HS 578t); Methods: RNA-seq was performed on paclitaxel-treated MDA-MB-436 cells that are resistant to Paclitaxel (R20A, R20B, R20C) and in control-treated (DMSO) parental MDA-MB-436 cells that are sensitive to Paclitaxel (DMSO); Results: We mapped about 20 million sequence reads per sample to the human genome (hg19) and identified identified differentially expressed genes; Conclusions: Our study identified genes significantly enriched or repressed in taxol-resistant cells relative to parental cells in both TNBC models (MDA_MB-436 and HS 578T) SOURCE: Genevieve Deblois (genevieve.deblois@mail.mcgill.ca) - Mathieu Lupien University Health Network, University of Toronto